Promoting meaningful clinical trial outcome measures for Duchenne muscular dystrophy

被引：3
|
作者：
Peav, H. [1 ]
Kennedy, A. [2 ]
Fischer, R.
Bronson, A.
Furlong, P.
机构：
[1] RTI Int, Res Triangle Pk, NC USA
[2] Parent Project Muscular Dystrophy, Hackensack, NJ USA
来源：
NEUROMUSCULAR DISORDERS | 2016年 / 26卷
关键词：
D O I：
10.1016/j.nmd.2016.06.366
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.337
引用
收藏
页码：S187 / S187
页数：1
相关论文
共 50 条
  • [21] The Black Box of Technological Outcome Measures: An Example in Duchenne Muscular Dystrophy
    Naarding, Karin J.
    Janssen, Mariska M. H. P.
    Boon, Ruben D.
    Bank, Paulina J. M.
    Matthew, Robert P.
    Kurillo, Gregorij
    Han, Jay J.
    Verschuuren, Jan J. G. M.
    de Groot, Imelda J. M.
    van der Holst, Menno
    Kan, Hermien E.
    Niks, Erik H.
    [J]. JOURNAL OF NEUROMUSCULAR DISEASES, 2022, 9 (04) : 555 - 569
  • [22] EXON SKIPPING AND DUCHENNE MUSCULAR DYSTROPHY: A CLINICAL TRIAL UPDATE
    Wilton, Steve
    Fletcher, Sue
    [J]. JOURNAL OF GENE MEDICINE, 2013, 15 (8-9): : 330 - 330
  • [23] The burden of participation in a clinical trial for boys with Duchenne muscular dystrophy
    Geuens, S.
    Willen, J.
    Antonis, C.
    Goemans, N.
    De Waele, L.
    [J]. NEUROMUSCULAR DISORDERS, 2018, 28 : S69 - S69
  • [24] Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: Implications for clinical trials
    Ricotti, V.
    Eagle, M.
    Butler, J.
    Decostre, V.
    Deborah, R.
    Moraux, A.
    Anthony, K.
    Sleby, V.
    Guglieri, M.
    van der Holst, M.
    Jansen, M.
    Morgan, J.
    de Groot, I.
    Niks, E.
    Verschuuren, J.
    Servais, L.
    Hogrel, J. Y.
    Voit, T.
    Straub, V.
    Muntoni, F.
    [J]. NEUROMUSCULAR DISORDERS, 2015, 25 : S229 - S229
  • [25] Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: implications for clinical trials
    Domingos, J.
    Eagle, M.
    Moraux, A.
    Butler, J.
    Decostre, V.
    Ridout, D.
    Mayhew, A.
    Selby, V.
    Reguiba, N.
    Guglieri, M.
    Van der Holst, M.
    Jansen, M.
    Verschuuren, J. G. M.
    de Groot, I.
    Niks, E.
    Servais, L.
    Hogrel, J. Y.
    Straub, V.
    Voit, T.
    Ricotti, V.
    Muntoni, F.
    [J]. NEUROMUSCULAR DISORDERS, 2016, 26 : S6 - S6
  • [26] Non-Invasive Respiratory Assessment in Duchenne Muscular Dystrophy: From Clinical Research to Outcome Measures
    Pennati, Francesca
    LoMauro, Antonella
    D'Angelo, Maria Grazia
    Aliverti, Andrea
    [J]. LIFE-BASEL, 2021, 11 (09):
  • [27] Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: implications for clinical trials
    Domingos, J.
    Eagle, M.
    Moraux, A.
    Butler, J.
    Decostre, V.
    Ridout, D.
    Mayhew, A.
    Selby, V.
    Guglieri, M.
    Van der Holst, M.
    Jansen, M.
    Verschuuren, J. G. M.
    de Groot, I.
    Niks, E.
    Servais, L.
    Hogrel, J. Y.
    Straub, V.
    Voit, T.
    Ricotti, V.
    Muntoni, F.
    [J]. NEUROMUSCULAR DISORDERS, 2017, 27 : S12 - S12
  • [28] Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: Implications for clinical trials
    Domingos, J.
    Eagle, M.
    Moraux, A.
    Butler, J.
    Decostre, V.
    Ridout, D.
    Mayhew, A.
    Selby, V.
    Guglieri, M.
    Van der Holst, M.
    Jansen, M.
    Verschuuren, J.
    de Groot, I.
    Niks, E.
    Servais, L.
    Hogrel, J. Y.
    Straub, V.
    Voit, T.
    Ricotti, V.
    Muntoni, F.
    [J]. NEUROMUSCULAR DISORDERS, 2016, 26 : S185 - S185
  • [29] Longitudinal reliability of clinical outcome measures and quantitative muscle MRI in ambulant patients with Duchenne muscular dystrophy
    Nagy, S.
    Schadelin, S.
    Hafner, P.
    Bonati, U.
    Schmidt, S.
    Orsini, A. -L.
    Bieri, O.
    Fischer, D.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 324 - 324
  • [30] Outcome measures in Duchenne muscular dystrophy: Are we ready for the new therapeutic era?
    Merkies, Ingemar S. J.
    Faber, Catharina G.
    [J]. NEUROMUSCULAR DISORDERS, 2009, 19 (06) : 447 - 447
12345